GlassScriptPhysician profile
Ryan Martin Gianatasio
NPI 1144489550
$2,636.67
in general payments reported to CMS, 2019-2025
11 companies · $601 in 2025
The $601 reported for 2025 was more than what a typical Vascular Neurology provider received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $349 · 2021: $218 · 2022: $275 · 2023: $308 · 2024: $753 · 2025: $601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,662.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $1,075.96 | 2021-2025 | Cerebase, Embotrap, Trufill |
| Medtronic, INC. | $489.47 | 2021-2025 | Pipeline, Solitaire X |
| Penumbra, INC. | $466.75 | 2019-2023 | Benchmark |
| Route 92 Medical, INC. | $270.97 | 2024-2025 | 8f Base Camp Sheath System |
| Medtronic USA, INC. | $144.24 | 2019-2020 | |
| Microvention, INC. | $58.53 | 2025 | Stent, Azur Cx Detachable |
| Chiesi USA, INC. | $42.93 | 2024 | Kengreal, Cleviprex |
| Qapel Medical INC | $37.78 | 2024 | |
| Stryker Corporation | $22.98 | 2022 | |
| Cardiva Medical, INC. | $16.32 | 2021 | |
| Scientia Vascular | $10.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Gianatasio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.